Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Identification of a 97-kDa Mastoparan-Binding Protein Involving in Ca2+ Release from Skeletal Muscle Sarcoplasmic Reticulum

Yutaka Hirata, Norimichi Nakahata and Yasushi Ohizumi
Molecular Pharmacology June 2000, 57 (6) 1235-1242;
Yutaka Hirata
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norimichi Nakahata
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasushi Ohizumi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Mastoparan (MP) and radiolabeled [Tyr3]MP caused a transient Ca2+ release from the heavy fraction of sarcoplasmic reticulum, which was inhibited by ryanodine. MP enhanced [3H]ryanodine binding in a concentration-dependent manner with an EC50 value of approximately 0.3 μM. The45Ca2+ release was accelerated by MP, [Tyr3]MP, or caffeine in a concentration-dependent manner. The EC50 values for MP, [Tyr3]MP, and caffeine were approximately 2.0 μM, 7.7 μM, and 1.8 mM, respectively. MP, like caffeine, shifted the stimulatory limb of a bell-shaped curve of Ca2+ dependence to the left.45Ca2+ release induced by caffeine was completely inhibited by typical blockers of Ca2+-induced Ca2+ release, such as Mg2+, ruthenium red, or procaine. However, 45Ca2+ release induced by MP was completely inhibited by Mg2+, but it was only partially inhibited by ruthenium red or procaine. The rate of45Ca2+ release induced by MP was further increased in the presence of caffeine, showing that the MP binding site is different from that of caffeine on Ca2+ release channels. We succeeded in the synthesis of125I-[Tyr3]MP with a high specific activity.125I-[Tyr3]MP bound specifically to heavy fraction of sarcoplasmic reticulum with a Kdvalue of 4.0 μM and a Bmax value of 3.0 nmol/mg. Furthermore, 125I-[Tyr3]MP specifically cross-linked to the 97-kDa protein without direct binding to ryanodine receptor. The protein was not triadin or Ca2+-pump, because antitriadin antibody and anti-Ca2+-pump antibody did not immunoprecipitate the protein. These results suggest that the 97-kDa MP-binding protein may have an important role in the excitation-contraction coupling of skeletal muscle.

Footnotes

  • Send reprint requests to: Professor Norimichi Nakahata, Department of Cellular Signaling, Graduate School of Pharmaceutical Sciences, Tohoku University, Aoba, Aramaki, Aoba-Ku, Sendai 980-8578, Japan. E-mail: nakahata{at}mail.pharm.tohoku.ac.jp

  • This work was partially supported by Research Fellowships of the Japan Society for the Promotion of Science for Young Scientists (Y.H.) and Grant-in-Aid for Scientific Research from the Ministry of Education, Sciences and Culture of Japan (N.N. and Y.O.).

  • Abbreviations:
    RyR
    ryanodine receptor
    SR
    sarcoplasmic reticulum
    MP
    mastoparan
    HSR
    heavy fraction of sarcoplasmic reticulum
    SR Ca2+-pump
    sarco/endoplasmic reticulum Ca2+-ATPase
    Sulfo-SANPAH
    sulfosuccinimidyl-6-[4′-azido-2′-nitrophenylamino] hexanoate
    CHAPS
    3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonic acid
    Fluo-3
    1-[2-amino-5-(2,7-dichloro-6-hydroxy-3-oxy-9-xanthenyl)phenoxy]-2-(2-amino-5-methylphenoxy)ethane-N,N,N′,N′-tetraacetic acid
    PAGE
    polyacrylamide gel electrophoresis
    MOPS
    3-(N-morpholino)propanesulfonic acid
    Ck
    creatinine kinase
    • Received August 30, 1999.
    • Accepted February 15, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 57 (6)
Molecular Pharmacology
Vol. 57, Issue 6
1 Jun 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of a 97-kDa Mastoparan-Binding Protein Involving in Ca2+ Release from Skeletal Muscle Sarcoplasmic Reticulum
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Identification of a 97-kDa Mastoparan-Binding Protein Involving in Ca2+ Release from Skeletal Muscle Sarcoplasmic Reticulum

Yutaka Hirata, Norimichi Nakahata and Yasushi Ohizumi
Molecular Pharmacology June 1, 2000, 57 (6) 1235-1242;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Identification of a 97-kDa Mastoparan-Binding Protein Involving in Ca2+ Release from Skeletal Muscle Sarcoplasmic Reticulum

Yutaka Hirata, Norimichi Nakahata and Yasushi Ohizumi
Molecular Pharmacology June 1, 2000, 57 (6) 1235-1242;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Experimental Procedures
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Cysteine151 in Keap1 Drives CDDO-Me Pharmacodynamic Action
  • Allosteric Modulation of Metabotropic Glutamate Receptor 1
  • Mechanism of Selective Action of Paraherquamide A
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics